{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:15:29Z","timestamp":1789348529997,"version":"build-2803163510"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.vph.2009.02.002","type":"journal-article","created":{"date-parts":[[2009,2,14]],"date-time":"2009-02-14T15:11:32Z","timestamp":1234624292000},"page":"1-7","source":"Crossref","is-referenced-by-count":88,"title":["Angiogenesis and its targeting in rheumatoid arthritis"],"prefix":"10.1016","volume":"51","author":[{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa E.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2009.02.002_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/ar2313","article-title":"Association of ITGAV supports the role of angiogenesis in rheumatoid arthritis","volume":"9","author":"Ahnert","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.vph.2009.02.002_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.RES.0000087641.56024.DA","article-title":"Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase","volume":"93","author":"Amin","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2009.02.002_bib3","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/art.22705","article-title":"Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways","volume":"56","author":"Amin","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.vph.2009.02.002_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/bbrc.1997.6435","article-title":"Interleukin-15 promotes angiogenesis in vivo","volume":"233","author":"Angiolillo","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2009.02.002_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0163-7258(94)90027-2","article-title":"Angiogenesis inhibition: a review","volume":"63","author":"Auerbach","year":"1994","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.vph.2009.02.002_bib6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/rheumatology\/keh423","article-title":"Treatment of active psoriatic arthritis with the PPAR\u03b3 ligand pioglitazone: an open-label pilot study","volume":"44","author":"Bongartz","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.vph.2009.02.002_bib7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/BOR.0b013e32805e87f1","article-title":"Update on cytokines in rheumatoid arthritis","volume":"19","author":"Brennan","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.vph.2009.02.002_bib8","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/art.21016","article-title":"Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction","volume":"52","author":"Chen","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.vph.2009.02.002_bib9","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D\u2019Amato","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vph.2009.02.002_bib10","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0092-8674(00)81812-7","article-title":"Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning","volume":"87","author":"Davis","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.vph.2009.02.002_bib11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-1-59745-401-8_22","article-title":"Angiogenesis in arthritis: methodological and analytical details","volume":"135","author":"Fearon","year":"2007","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.vph.2009.02.002_bib12","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1002\/art.22161","article-title":"Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures","volume":"54","author":"Fearon","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.vph.2009.02.002_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1126\/science.2432664","article-title":"Angiogenic factors","volume":"235","author":"Folkman","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.vph.2009.02.002_bib14","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1186\/ar756","article-title":"Upregulated hypoxia inducible factor-1\u03b1 and -2\u03b1 pathway in rheumatoid arthritis and osteoarthritis","volume":"5","author":"Giatromanolaki","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.vph.2009.02.002_bib15","doi-asserted-by":"crossref","first-page":"R326","DOI":"10.1186\/ar1182","article-title":"Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy","volume":"6","author":"Goedkoop","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.vph.2009.02.002_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/ard.62.2.100","article-title":"Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha","volume":"62","author":"Gravallese","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.vph.2009.02.002_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00011-003-1230-4","article-title":"Angiogenesis inhibition by the novel VEGF tyrosine kinase inhibitor, PTK787\/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis","volume":"53","author":"Grosios","year":"2004","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.vph.2009.02.002_bib18","doi-asserted-by":"crossref","first-page":"26294","DOI":"10.1074\/jbc.M609711200","article-title":"Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis","volume":"282","author":"Guttmann-Raviv","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2009.02.002_bib19","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/art.22034","article-title":"Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis","volume":"54","author":"Haas","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.vph.2009.02.002_bib20","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/art.22823","article-title":"In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis","volume":"56","author":"Haas","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.vph.2009.02.002_bib21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/art.22402","article-title":"Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI-2458","volume":"56","author":"Hannig","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.vph.2009.02.002_bib22","first-page":"51","article-title":"Serum and synovial fluid concentrations of endothelin-1 in patients with inflammatory arthritides","volume":"30","author":"Haq","year":"1999","journal-title":"J. Med."},{"key":"10.1016\/j.vph.2009.02.002_bib23","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","article-title":"Vessel cooption, regression and growth in tumors mediated by angiopoietins and VEGF","volume":"284","author":"Holash","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vph.2009.02.002_bib24","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1073\/pnas.172398299","article-title":"VEGF-Trap: a VEGF blocker with potent antitumor effects","volume":"99","author":"Holash","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vph.2009.02.002_bib25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2249.2006.03295.x","article-title":"Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts","volume":"147","author":"Hong","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.vph.2009.02.002_bib26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/348555a0","article-title":"Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth","volume":"348","author":"Ingber","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.vph.2009.02.002_bib27","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar2221","article-title":"European Consortium on Rheumatoid Arthritis Families. The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study","volume":"9","author":"Jacq","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.vph.2009.02.002_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780360203","article-title":"Adhesion molecule expression in human synovial tissues","volume":"36","author":"Johnson","year":"1993","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.vph.2009.02.002_bib29","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/ar2181","article-title":"Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis","volume":"26","author":"Kim","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.vph.2009.02.002_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1517\/13543784.16.1.83","article-title":"VEGF\/VEGFR signaling as a target for inhibiting angiogenesis","volume":"16","author":"Kiselyov","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.vph.2009.02.002_bib31","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/art.22602","article-title":"Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice","volume":"56","author":"Kneilling","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.vph.2009.02.002_bib32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D","article-title":"Angiogenesis: implications for rheumatoid arthritis","volume":"41","author":"Koch","year":"1998","journal-title":"Arthritis Rheum."},{"issue":"Suppl 2","key":"10.1016\/j.vph.2009.02.002_bib33","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar2187","article-title":"Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis","volume":"9","author":"Koch","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.vph.2009.02.002_bib34","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.4049\/jimmunol.152.8.4149","article-title":"Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis","volume":"152","author":"Koch","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2009.02.002_bib35","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.lfs.2005.10.016","article-title":"Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA.hy926 cells","volume":"78","author":"Komorowski","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.vph.2009.02.002_bib36","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ncprheum0559","article-title":"Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis","volume":"3","author":"Lainer-Carr","year":"2007","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.vph.2009.02.002_bib37","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.4049\/jimmunol.177.8.5585","article-title":"Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis","volume":"177","author":"Lee","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2009.02.002_bib38","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.bbrc.2007.05.182","article-title":"CXCR4\/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway","volume":"359","author":"Liang","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2009.02.002_bib39","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1006\/bbrc.2002.6551","article-title":"Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1","volume":"291","author":"Liu","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2009.02.002_bib40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1535-6108(03)00077-1","article-title":"2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF","volume":"3","author":"Mabjeesh","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.vph.2009.02.002_bib41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1083\/jcb.97.1.153","article-title":"Capillary endothelial cell cultures: phenotypic modulation by matrix components","volume":"97","author":"Madri","year":"1983","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.vph.2009.02.002_bib42","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1182\/blood-2006-07-036400","article-title":"MCP-1 mediates TGF-beta-induced angiogenesis by stimulating vascular smooth muscle cell migration","volume":"109","author":"Ma","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.vph.2009.02.002_bib43","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaad.2006.01.038","article-title":"Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy","volume":"54","author":"Markham","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.vph.2009.02.002_bib44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.biocel.2005.10.006","article-title":"Regulators of angiogenesis and strategies for their respective manipulation","volume":"38","author":"Milkiewicz","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.vph.2009.02.002_bib45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrd2029","article-title":"MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis","volume":"5","author":"Morand","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.vph.2009.02.002_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mvr.2007.05.005","article-title":"Type IV collagen-derived angiogenesis inhibitors","volume":"74","author":"Mundel","year":"2007","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.vph.2009.02.002_bib47","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1182\/blood-2006-04-016030","article-title":"Signalling of vascular endothelial growth factor receptor 1 tyrosine kinase promotes rheumatoid arthritis through the activation of monocytes\/macrophages","volume":"108","author":"Murakami","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.vph.2009.02.002_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-065X.2007.00506.x","article-title":"Synovial mast cells: role in acute and chronic arthritis","volume":"217","author":"Nigrovic","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.vph.2009.02.002_bib49","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.4049\/jimmunol.175.9.6177","article-title":"IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR2-dependent angiogenesis","volume":"175","author":"Numasaki","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2009.02.002_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O\u2019Reilly","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.vph.2009.02.002_bib51","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.4049\/jimmunol.179.8.5504","article-title":"Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice","volume":"179","author":"Okunishi","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2009.02.002_bib52","first-page":"964","article-title":"The effect of thalidomide and two analogs on collagen induced arthritis","volume":"25","author":"Oliver","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.vph.2009.02.002_bib53","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.4049\/jimmunol.170.4.2147","article-title":"Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis","volume":"170","author":"Pablos","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2009.02.002_bib54","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4049\/jimmunol.167.3.1644","article-title":"Evidence of IL-18 as a novel angiogenic mediator","volume":"167","author":"Park","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2009.02.002_bib55","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0002-9440(10)63259-2","article-title":"Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis","volume":"165","author":"Park","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.vph.2009.02.002_bib56","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.175.4.1135","article-title":"Angiogenesis inhibition suppresses collagen arthritis","volume":"175","author":"Peacock","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vph.2009.02.002_bib57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.it.2007.05.007","article-title":"The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis","volume":"28","author":"Petit","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.vph.2009.02.002_bib58","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/jcp.20958","article-title":"Amelioration of inflammation, angiogenesis and CTGF expression in an arthritis model by a TSP-1-derived peptide treatment","volume":"211","author":"Rico","year":"2007","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.vph.2009.02.002_bib59","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1","article-title":"Fractalkine, a novel chemokine in rheumatoid arthritis and rat adjuvant-induced arthritis","volume":"44","author":"Ruth","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.vph.2009.02.002_bib60","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0002-9440(10)65365-5","article-title":"Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha","volume":"154","author":"Salcedo","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.vph.2009.02.002_bib61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood.V96.1.34","article-title":"Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression","volume":"96","author":"Salcedo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.vph.2009.02.002_bib62","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar407","article-title":"Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue","volume":"4","author":"Shahrara","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.vph.2009.02.002_bib63","doi-asserted-by":"crossref","first-page":"R112","DOI":"10.1186\/ar2318","article-title":"Differential expression of the FAK family kinases in rheumatoid arthritis and osteoarthritis synovial tissues","volume":"9","author":"Shahrara","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.vph.2009.02.002_bib64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1749-6632.1999.tb07674.x","article-title":"Design and synthetic considerations of matrix metalloproteinase inhibitors","volume":"878","author":"Skotnicki","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.vph.2009.02.002_bib65","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbrc.2005.12.037","article-title":"Human CC chemokine CCL23 enhances expression of matrix metalloproteinase-2 and invasion of vascular endothelial cells","volume":"340","author":"Son","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2009.02.002_bib66","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.177.4.2651","article-title":"CCL2 regulates angiogenesis via activation of Ets-1 transcription factor","volume":"177","author":"Stamatovic","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2009.02.002_bib67","doi-asserted-by":"crossref","first-page":"27348","DOI":"10.1074\/jbc.270.45.27348","article-title":"The functional role of the ELR motif in CXC chemokine-mediated angiogenesis","volume":"270","author":"Strieter","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2009.02.002_bib68","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/ar608","article-title":"The angiogenesis inhibitor protease-activated kringles 1\u20135 reduces the severity of murine collagen-induced arthritis","volume":"5","author":"Sumariwalla","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.vph.2009.02.002_bib69","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","article-title":"Requisite role of angiopoietin-1 a ligand for the TIE2 receptor, during embryonic angiogenesis","volume":"87","author":"Suri","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.vph.2009.02.002_bib70","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00002281-200105000-00009","article-title":"Chemokines and angiogenesis","volume":"13","author":"Szekanecz","year":"2001","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.vph.2009.02.002_bib71","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0889-857X(03)00116-9","article-title":"Vascular endothelium and immune responses: implications for inflammation and angiogenesis","volume":"30","author":"Szekanecz","year":"2004","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.vph.2009.02.002_bib72","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/BOR.0b013e32805e87ae","article-title":"Macrophages and their products in rheumatoid arthritis","volume":"19","author":"Szekanecz","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.vph.2009.02.002_bib73","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00832002","article-title":"Chemokines in rheumatoid arthritis","volume":"20","author":"Szekanecz","year":"1998","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.vph.2009.02.002_bib74","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00002512-199812050-00004","article-title":"Cytokines in rheumatoid arthritis: potential targets for pharmacological intervention","volume":"12","author":"Szekanecz","year":"1998","journal-title":"Drugs Aging"},{"key":"10.1016\/j.vph.2009.02.002_bib75","first-page":"27","article-title":"Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance","volume":"46","author":"Szekanecz","year":"1998","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.vph.2009.02.002_bib76","first-page":"1","article-title":"Chemokines and chemokine receptors in rheumatoid arthritis","volume":"399","author":"Szekanecz","year":"2002","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.vph.2009.02.002_bib77","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2741\/1657","article-title":"Angiogenesis in rheumatoid arthritis","volume":"10","author":"Szekanecz","year":"2005","journal-title":"Front. Biosci."},{"key":"10.1016\/j.vph.2009.02.002_bib78","first-page":"455","article-title":"Adeno-associated virus vector-mediated anti-angiogenic gene therapy for collagen-induced arthritis in mice","volume":"23","author":"Takahashi","year":"2005","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.vph.2009.02.002_bib79","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1073\/pnas.072586399","article-title":"A role for survivin in chemoresistance of endothelial cells mediated by VEGF","volume":"99","author":"Tran","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vph.2009.02.002_bib80","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.berh.2006.05.004","article-title":"Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting","volume":"20","author":"Veale","year":"2006","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.vph.2009.02.002_bib81","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0002-9440(10)62537-0","article-title":"Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis","volume":"159","author":"Volin","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.vph.2009.02.002_bib82","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/38.2.103","article-title":"Angiogenesis and arthritis","volume":"38","author":"Walsh","year":"1999","journal-title":"Rheumatology (Oxford),"},{"key":"10.1016\/j.vph.2009.02.002_bib83","series-title":"Chemokines in Disease","first-page":"1","article-title":"C\u2013X\u2013C chemokines \u2014 an overview","author":"Walz","year":"1996"},{"key":"10.1016\/j.vph.2009.02.002_bib84","first-page":"2171","article-title":"Upregulation of kallistatin expression in rheumatoid joints","volume":"34","author":"Wang","year":"2007","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.vph.2009.02.002_bib85","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canlet.2005.10.041","article-title":"Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis","volume":"241","author":"Wente","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.vph.2009.02.002_bib86","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jnci\/95.7.516","article-title":"YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1","volume":"95","author":"Yeo","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.vph.2009.02.002_bib87","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1006\/mthe.2002.0590","article-title":"Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis","volume":"5","author":"Yin","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.vph.2009.02.002_bib88","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejphar.2007.03.057","article-title":"Blockage of the formation of new blood vessels by recombinant human endostatin contributes to the regression of rat adjuvant arthritis","volume":"567","author":"Yue","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2009.02.002_bib89","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.gt.3302756","article-title":"Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma","volume":"13","author":"Zhang","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.vph.2009.02.002_bib90","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/FJC.0b013e318093ec8f","article-title":"Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1\u03b1\/CXCR4 via PI3K\/Akt\/eNOS signal transduction pathway","volume":"50","author":"Zheng","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189109000214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189109000214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:53:44Z","timestamp":1684889624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189109000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1537189109000214"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2009.02.002","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}